Filing Details
- Accession Number:
- 0001209191-22-002462
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-07 17:12:28
- Reporting Period:
- 2021-12-01
- Accepted Time:
- 2022-01-07 17:12:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1684087 | Caroline Young | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-01 | 18 | $4.14 | 14,401 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-02 | 18 | $3.84 | 14,419 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-03 | 18 | $4.47 | 14,437 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-06 | 18 | $4.46 | 14,455 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-07 | 18 | $5.61 | 14,473 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-08 | 18 | $6.15 | 14,491 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-09 | 18 | $5.81 | 14,509 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-10 | 18 | $4.82 | 14,527 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-13 | 30 | $4.36 | 14,557 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-14 | 30 | $4.28 | 14,587 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-15 | 30 | $4.29 | 14,617 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-16 | 50 | $4.53 | 14,667 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-17 | 50 | $4.17 | 14,717 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-20 | 60 | $4.33 | 14,777 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.